LEARN Harm Reduction: A Collaborative Organizational Intervention in the US South

References

• Abdul-Quader, A. S., Feelemyer, J., Modi, S., Stein, E. S., Briceno, A., Semaan, S., Horvath, T., Kennedy, G. E., & Des Jarlais, D. C. (2013). Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who  inject drugs: A systematic review. AIDS and Behavior, 17(9), 2878–2892. https://doi.org/10.1007/s10461-013-0593-y
   PubMed Web of Science ®Google Scholar
• Artiga, S., & Damico, A. (2016). Health and health coverage in the South: A data update (Issue Brief). Kaiser Family Foundation. https://www.kff.org/disparities-policy/issue-brief/health-and-health-coverage-in-the-south-a-data-update/
   Google Scholar
• Ball, A. L. (2007). HIV, injecting drug use and harm reduction: A public health response. Addiction, 102(5), 684–690. https://doi.org/10.1111/j.1360-0443.2007.01761.x
   PubMed Web of Science ®Google Scholar
• Biello, K. B., Bazzi, A. R., Mimiaga, M. J., Biancarelli, D. L., Edeza, A., Salhaney, P., Childs, E., & Drainoni, M. L. (2018). Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs. Harm Reduction Journal, 15(1), 1–12. https://doi.org/10.1186/s12954-018-0263-5
   PubMed Web of Science ®Google Scholar
• Black AIDS Institute. (2020). We the people: A black plan to end HIV (Research Report No. 1.0). Black AIDS Institute. https://indd.adobe.com/view/f5149b92-3f31-4996-b948-4aaf7a73d3d7
   Google Scholar
• Bos, N., Zimmerman, A., Olson, J., Yew, J., Yerkie, J., Dahl, E., & Olson, G. (2007). From shared databases to communities of practice: A taxonomy of collaboratories. Journal of Computer-Mediated Communication, 12(2), 652–672. https://doi.org/10.1111/j.1083-6101.2007.00343.x
   Web of Science ®Google Scholar
• Boyatzis, R. E. (1998). Transforming qualitative information: Thematic analysis and code development. Sage Publications.
   Google Scholar
• Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101. https://doi.org/10.1191/1478088706qp063oa
   Google Scholar
• Brooner, R., Kidorf, M., King, V., Beilenson, P., Svikis, D., & Vlahov, D. (1998). Drug abuse treatment success among needle exchange participants. Public Health Reports, 113(Suppl. 1), 129.
   PubMedGoogle Scholar
• Campbell, A. N., Wolff, M., Weaver, L., Des Jarlais, D. C., & Tross, S. (2018). “It’s never just about the HIV:” HIV primary care providers’ perception of substance use in the era of “universal” antiretroviral medication treatment. AIDS and Behavior, 22(3), 1006–1017. https://doi.org/10.1007/s10461-017-2007-z
   PubMed Web of Science ®Google Scholar
• Caponnetto, P., Campagna, D., Cibella, F., Morjaria, J. B., Caruso, M., Russo, C., & Polosa, R. (2013). EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: A prospective 12-month randomized control design study. PLoS One, 8(6), e66317. https://doi.org/10.1371/journal.pone.0066317
   PubMed Web of Science ®Google Scholar
• Carlberg-Racich, S. (2016). Harm reduction interventions in HIV care: A qualitative exploration of patient and provider perspectives. PeerJ, 4, e1932. https://doi.org/10.7717/peerj.1932
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2019). HIV in the Southern United States (Issue Brief). Centers for Disease Control and Prevention. https://www.cdc.gov/hiv/pdf/policies/cdc-hiv-in-the-south-issue-brief.pdf
   Google Scholar
• Charlet, K., & Heinz, A. (2017). Harm reduction—A systematic review on effects of alcohol reduction on physical and mental symptoms. Addiction Biology, 22(5), 1119–1159. https://doi.org/10.1111/adb.12414
   PubMed Web of Science ®Google Scholar
• Cho, S. M. (2007). Assessing organizational effectiveness in human service organizations: An empirical review of conceptualization and determinants. Journal of Social Service Research, 33(3), 31–45. https://doi.org/10.1300/J079v33n03_04
   Web of Science ®Google Scholar
• Cusick, L. (2006). Widening the harm reduction agenda: From drug use to sex work. International Journal of Drug Policy, 17(1), 3–11. https://doi.org/10.1016/j.drugpo.2005.12.002
   Web of Science ®Google Scholar
• Des Jarlais, D. C., Arasteh, K., McKnight, C., Hagan, H., Perlman, D., & Friedman, S. R. (2009). Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City. Drug and Alcohol Dependence, 101(1-2), 88–91. https://doi.org/10.1016/j.drugalcdep.2008.11.007
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., & Friedman, S. R. (1996). HIV epidemiology and interventions among injecting drug users. International Journal of STD & AIDS, 7(2_suppl), 57–61. https://doi.org/10.1258/0956462961917654
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Perlis, T., Arasteh, K., Torian, L. V., Hagan, H., Beatrice, S., Smith, L., Wethers, J., Milliken, J., Mildvan, D., Yancovitz, S., & Friedman, S. R. (2005). Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990–2001. AIDS, 19(Suppl 3), S20–S25. https://doi.org/10.1097/01.aids.0000192066.86410.8c
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Perlis, T., Friedman, S. R., Deren, S., Chapman, T., Sotheran, J. L., Tortu, S., Beardsley, M., Paone, D., Torian, L. V., Beatrice, S. T., DeBernardo, E., Monterroso, E., & Marmor, M. (1998). Declining seroprevalence in a very large HIV epidemic: Injecting drug users in New York City, 1991 to 1996. American Journal of Public Health, 88(12), 1801–1806. https://doi.org/10.2105/AJPH.88.12.1801
   PubMed Web of Science ®Google Scholar
• Downing, M., Mulia, N., Vernon, K., Knight, K., Ferreboeuf, M., & Carroll, A. (2000). Voices from the field: Providers discuss HIV counseling and testing programs for drug users. AIDS & Public Policy Journal, 15(2), 48–64.
   PubMedGoogle Scholar
• Fullerton, C. A., Kim, M., Thomas, C. P., Lyman, R., Montejano, L. B., Dougherty, R. H., Daniels, A. S., Ghose, S. S., & Delphin-Rittmon, M. E. (2014). Medication-assisted treatment with methadone: Assessing the evidence. Psychiatric Services, 65(2), 146–157. https://doi.org/10.1176/appi.ps.201300235
   PubMed Web of Science ®Google Scholar
• Gwadz, M., de Guzman, R., Freeman, R., Kutnick, A., Silverman, E., Leonard, N. R., Ritchie, A. S., Muñoz-Plaza, C., Salomon, N., Wolfe, H., Hilliard, C., Cleland, C. M., & Honig, S. (2016). Exploring how substance use impedes engagement along the HIV care continuum: A qualitative study. Frontiers in Public Health, 4, 62. https://doi.org/10.3389/fpubh.2016.00062
   PubMed Web of Science ®Google Scholar
• Hagan, H., Jarlais, D. C., Friedman, S. R., Purchase, D., & Alter, M. J. (1995). Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. American Journal of Public Health, 85(11), 1531–1537. https://doi.org/10.2105/ajph.85.11.1531
   PubMed Web of Science ®Google Scholar
• Hagan, H., McGough, J. P., Thiede, H., Hopkins, S., Duchin, J., & Alexander, E. R. (2000). Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. Journal of Substance Abuse Treatment, 19(3), 247–252. https://doi.org/10.1016/S0740-5472(00)00104-5
   PubMed Web of Science ®Google Scholar
• Harm Reduction Coalition. (2020). Principles of harm reduction. https://harmreduction.org/about-us/principles-of-harm-reduction/
   Google Scholar
• Hawk, M., Coulter, R. W. S., Egan, J. E., Fisk, S., Friedman, M. R., Tula, M., & Kinsky, S. (2017). Harm reduction principles for healthcare settings. Harm Reduction Journal, 14(1), 1–9. https://doi.org/10.1186/s12954-017-0196-4
   PubMed Web of Science ®Google Scholar
• Heimer, R., Khoshnood, K., Bigg, D., Guydish, J., & Junge, B. (1998). Syringe use and reuse: Effects of syringe exchange programs in four cities. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, S37–S44. https://doi.org/10.1097/00042560-199802001-00008
   PubMedGoogle Scholar
• Inciardi, J. A., & Harrison, L. D. (1999). Harm reduction: National and international perspectives. Sage Publications.
   Google Scholar
• Iyengar, S., Kravietz, A., Bartholomew, T. S., Forrest, D., & Tookes, H. E. (2019). Baseline differences in characteristics and risk behaviors among people who inject drugs by syringe exchange program modality: An analysis of the Miami IDEA syringe exchange. Harm Reduction Journal, 16(1), 7. https://doi.org/10.1186/s12954-019-0280-z
   PubMed Web of Science ®Google Scholar
• Jahanfar, S., & Myers, J. (2018). Harm reduction interventions to prevent HIV/AIDS transmission in involuntary detainees. The Cochrane Database of Systematic Reviews, 2018(6).
   Google Scholar
• Le, T. N., & Alefaio, D. (2019). Mindfulness training for social service providers in Hawaii: Context and considerations. Journal of Social Service Research, 524–537.
   Web of Science ®Google Scholar
• Lee, H. S., & Zerai, A. (2010). “Everyone deserves services no matter what”: Defining success in harm-reduction-based substance user treatment. Substance Use & Misuse, 45(14), 2411–2427. https://doi.org/10.3109/10826081003712060
   PubMed Web of Science ®Google Scholar
• Levine, H., Bartholomew, T. S., Rea-Wilson, V., Onugha, J., Arriola, D. J., Cardenas, G., Forrest, D. W., Kral, A. H., Metsch, L. R., Spencer, E., & Tookes, H. (2019). Syringe disposal among people who inject drugs before and after the implementation of a syringe services program. Drug and Alcohol Dependence, 202, 13–17. https://doi.org/10.1016/j.drugalcdep.2019.04.025
   PubMed Web of Science ®Google Scholar
• Lurie, P., & Drucker, E. (1997). An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA. The Lancet, 349(9052), 604–608. https://doi.org/10.1016/S0140-6736(96)05439-6
   PubMed Web of Science ®Google Scholar
• Macalino, G. E., Sachdev, D. D., Rich, J. D., Becker, C., Tan, L. J., Beletsky, L., & Burris, S. (2009). A national physician survey on prescribing syringes as an HIV prevention measure. Substance Abuse Treatment, Prevention, and Policy, 4(1), 13. https://doi.org/10.1186/1747-597X-4-13
   PubMed Web of Science ®Google Scholar
• Mitchell, C., & Sackney, L. (2011). Profound improvement: Building capacity for a learning community. Taylor & Francis. https://doi.org/10.4324/9780203826027
   Google Scholar
• National Institute on Drug Abuse. (2020). Opioid summaries by state. National Institute on Drug Abuse. Retrieved May 13, 2020, from https://www.drugabuse.gov/drugs-abuse/opioids/opioid-summaries-by-state
   Google Scholar
• Overs, C., & Longo, P. (1997). Making sex work safe. Network of Sex Work Projects.
   Google Scholar
• Palamar, J. J. (2013). An examination of beliefs and opinions about drug use in relation to personal stigmatization towards drug users. Journal of Psychoactive Drugs, 45(5), 367–373. https://doi.org/10.1080/02791072.2013.843044
   PubMed Web of Science ®Google Scholar
• Patterson Silver Wolf, D. A., Ramsey, A. T., & van den Berk-Clark, C. (2015). Implementing outside the box: Community-based social service provider experiences with using an alcohol screening and intervention. Journal of Social Service Research, 41(2), 233–245. https://doi.org/10.1080/01488376.2014.980963
   PubMed Web of Science ®Google Scholar
• Pauly, B. M., MacKinnon, K., & Varcoe, C. (2009). Revisiting "Who gets care?": Health equity as an arena for nursing action. ANS. Advances in Nursing Science, 32(2), 118–127. https://doi.org/10.1097/ANS.0b013e3181a3afaf
   PubMed Web of Science ®Google Scholar
• Pinto, R. M., Chen, Y., & Park, S. E. (2019). A client-centered relational framework on barriers to the integration of HIV and substance use services: A systematic review. Harm Reduction Journal, 16(1), 71. https://doi.org/10.1186/s12954-019-0347-x
   PubMed Web of Science ®Google Scholar
• Reif, S., Wilson, E., & McAllaster, C. (2018). Perceptions and impact of HIV stigma among high risk populations in the US Deep South. Journal of HIV and AIDS, 4(2). https://doi.org/10.16966/2380-5536.154
   Google Scholar
• Reif, S., Wilson, E., McAllaster, C., & Pence, B. (2019). The relationship of HIV-related stigma and health care outcomes in the US Deep South. AIDS and Behavior, 23(S3), 242–250. https://doi.org/10.1007/s10461-019-02595-5
   PubMed Web of Science ®Google Scholar
• Rekart, M. K. (2005). Sex-work harm reduction. The Lancet, 366(9503), 2123–2134. https://doi.org/10.1016/S0140-6736(05)67732-X
   PubMed Web of Science ®Google Scholar
• Ritter, A., & Cameron, J. (2006). A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs. Drug and Alcohol Review, 25(6), 611–624. https://doi.org/10.1080/09595230600944529
   PubMed Web of Science ®Google Scholar
• Roth, A. M., Aumaier, B. L., Felsher, M. A., Welles, S. L., Martinez-Donate, A. P., Chavis, M., & Van Der Pol, B. (2018). An exploration of factors impacting preexposure prophylaxis eligibility and access among syringe exchange users. Sexually Transmitted Diseases, 45(4), 217–221. https://doi.org/10.1097/OLQ.0000000000000728
   PubMed Web of Science ®Google Scholar
• Shrestha, R., & Copenhaver, M. (2018). Exploring the use of pre-exposure prophylaxis (PrEP) for HIV prevention among high-risk people who use drugs in treatment. Frontiers in Public Health, 6, 195. https://doi.org/10.3389/fpubh.2018.00195
   PubMed Web of Science ®Google Scholar
• Spector, A. Y., Remien, R. H., & Tross, S. (2015). PrEP in substance abuse treatment: A qualitative study of treatment provider perspectives. Substance Abuse Treatment, Prevention, and Policy, 10(1), 1. https://doi.org/10.1186/1747-597X-10-1
   PubMed Web of Science ®Google Scholar
• Story, C. R., Southern Harm Reduction Coalition, Kao, W. K., Currin, J., Brown, C., & Charles, V. (2018). Evaluation of the Southern Harm Reduction Coalition for HIV prevention: Advocacy accomplishments. Health Promotion Practice, 19(5), 695–703. https://doi.org/10.1177/1524839917742850
   PubMed Web of Science ®Google Scholar
• Strathdee, S., Ricketts, E., Huettner, S., Cornelius, L., Bishai, D., Havens, J. R., Beilenson, P., Rapp, C., Lloyd, J. J., & Latkin, C. A. (2006). Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial. Drug and Alcohol Dependence, 83(3), 225–232. https://doi.org/10.1016/j.drugalcdep.2005.11.015
   PubMed Web of Science ®Google Scholar
• Tookes, H. E., Kral, A. H., Wenger, L. D., Cardenas, G. A., Martinez, A. N., Sherman, R. L., Pereyra, M., Forrest, D. W., LaLota, M., & Metsch, L. R. (2012). A comparison of syringe disposal practices among injection drug users in a city with versus a city without needle and syringe programs. Drug and Alcohol Dependence, 123(1-3), 255–259. https://doi.org/10.1016/j.drugalcdep.2011.12.001
   PubMed Web of Science ®Google Scholar
• Turner, B. J., Laine, C., Lin, Y. T., & Lynch, K. (2005). Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence. Archives of Internal Medicine, 165(15), 1769–1776. https://doi.org/10.1001/archinte.165.15.1769
   PubMed Web of Science ®Google Scholar
• Valdiserri, R. O., & Sullivan, P. S. (2018). Data visualization promotes sound public health practice: The AIDSvu example. AIDS Education and Prevention, 30(1), 26–34.
   Google Scholar
• Watters, J. K. (1994). Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA: The Journal of the American Medical Association, 271(2), 115–120. https://doi.org/10.1001/jama.271.2.115
   PubMed Web of Science ®Google Scholar
• Wenger, E. (2009). Communities of practice. Communities, 22(5),1–7.
   Google Scholar
• Westergaard, R. P., Ambrose, B. K., Mehta, S. H., & Kirk, G. D. (2012). Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers . Journal of the International AIDS Society, 15(1), 10–10. https://doi.org/10.1186/1758-2652-15-10
   PubMed Web of Science ®Google Scholar
• Wodak, A., & Cooney, A. (2006). Do needle syringe programs reduce HIV infection among injecting drug users: A comprehensive review of the international evidence. Substance Use & Misuse, 41(6-7), 777–813. https://doi.org/10.1080/10826080600669579
   PubMed Web of Science ®Google Scholar
• Wodak, A., & Maher, L. (2010). The effectiveness of harm reduction in preventing HIV among injecting drug users. New South Wales Public Health Bulletin, 21(3-4), 69–73. https://doi.org/10.1071/NB10007
   PubMedGoogle Scholar
• Wright, P. B., Curran, G. M., Stewart, K. E., & Booth, B. M. (2013). A qualitative analysis of provider barriers and solutions to HIV testing for substance users in a small, largely rural Southern state. The Journal of Rural Health, 29(4), 420–431. https://doi.org/10.1111/jrh.12021
   PubMed Web of Science ®Google Scholar
• Vaismoradi, M., Jones, J., Turunen, H., & Snelgrove, S. (2016). Theme development in qualitative content analysis and thematic analysis. Journal of Nursing Education and Practice, 6(5), 100–110. https://doi.org/10.5430/jnep.v6n5p100
   Google Scholar
• Volkow, N. D., & Montaner, J. (2011). The urgency of providing comprehensive and integrated treatment for substance abusers with HIV. Health Affairs (Project Hope), 30(8), 1411–1419. https://doi.org/10.1377/hlthaff.2011.0663
   PubMed Web of Science ®Google Scholar
• Zoom Video Communications, Inc. (2020). Zoom (Version 4.6.10) [Computer Software]. https://zoom.us
   Google Scholar